Additional file 5 of Immunogenicity of monkeypox virus surface proteins and cross-reactive antibody responses in vaccinated and infected individuals: implications for vaccine and therapeutic development

Supplementary Material 5: Table S1. Basic information of complete genome sequences in phylogenetic tree. Table S2. Factors associated with the seropositivity of antibody and VACV neutralization capacity in all groups (sex, MPXV infection, VACV vaccinated and age) Table S3. Factors associated with the seropositivity of antibody and VACV neutralization capacity in MPXV-infected individuals (MXPV CT value, CD4 + count, CD4 + /CD8 + and HIV viral load). Table S4. MPXV antigen amino acid similarity within OPXVs. CI,confidence interval; EC50, Median effect concentration; HIV, Human immunodeficiency virus; ID50, 50% inhibitory dilutions; MPXV, Monkeypox virus; OPXV, Orthopoxvirus; SPXV, Smallpox virus; TT, Tiantan; VACV, Vaccinia virus; WR, Western Reserve.